1. Home
  2. NXTC vs TWG Comparison

NXTC vs TWG Comparison

Compare NXTC & TWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXTC
  • TWG
  • Stock Information
  • Founded
  • NXTC 2015
  • TWG 2009
  • Country
  • NXTC United States
  • TWG Hong Kong
  • Employees
  • NXTC N/A
  • TWG N/A
  • Industry
  • NXTC Biotechnology: Pharmaceutical Preparations
  • TWG
  • Sector
  • NXTC Health Care
  • TWG
  • Exchange
  • NXTC Nasdaq
  • TWG NYSE
  • Market Cap
  • NXTC 9.3M
  • TWG 7.7M
  • IPO Year
  • NXTC 2019
  • TWG 2024
  • Fundamental
  • Price
  • NXTC $0.41
  • TWG $0.18
  • Analyst Decision
  • NXTC Strong Buy
  • TWG
  • Analyst Count
  • NXTC 2
  • TWG 0
  • Target Price
  • NXTC $3.50
  • TWG N/A
  • AVG Volume (30 Days)
  • NXTC 178.3K
  • TWG 6.3M
  • Earning Date
  • NXTC 05-01-2025
  • TWG 02-15-2025
  • Dividend Yield
  • NXTC N/A
  • TWG N/A
  • EPS Growth
  • NXTC N/A
  • TWG N/A
  • EPS
  • NXTC N/A
  • TWG 0.02
  • Revenue
  • NXTC N/A
  • TWG $14,375,689.00
  • Revenue This Year
  • NXTC N/A
  • TWG N/A
  • Revenue Next Year
  • NXTC N/A
  • TWG N/A
  • P/E Ratio
  • NXTC N/A
  • TWG $8.95
  • Revenue Growth
  • NXTC N/A
  • TWG 21.97
  • 52 Week Low
  • NXTC $0.22
  • TWG $0.13
  • 52 Week High
  • NXTC $1.82
  • TWG $13.50
  • Technical
  • Relative Strength Index (RSI)
  • NXTC 45.41
  • TWG N/A
  • Support Level
  • NXTC $0.34
  • TWG N/A
  • Resistance Level
  • NXTC $0.47
  • TWG N/A
  • Average True Range (ATR)
  • NXTC 0.06
  • TWG 0.00
  • MACD
  • NXTC 0.01
  • TWG 0.00
  • Stochastic Oscillator
  • NXTC 39.66
  • TWG 0.00

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

About TWG TOP WEALTH GROUP HLDG LTD

Top Wealth Group Holding Ltd is as supplier of caviar and offer caviar-based gourmet products. It is specialized in supplying high quality sturgeons caviar.

Share on Social Networks: